Navigation Links
MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
Date:10/29/2007

SAN FRANCISCO, October 29, 2007 MedImmune today announced results from a recent economic analysis of Synagis (palivizumab), a monoclonal antibody (MAb) that is the standard of care for prevention of severe lower respiratory tract infection due to respiratory syncytial virus (RSV) in high-risk infants. Released at the American Academy of Pediatrics (AAP) 2007 National Conference & Exhibition, the analysis evaluated the costs of providing Synagis to premature infants, as well as the potential health benefits and cost savings that could occur from lower rates of severe RSV infections.

RSV can cause severe lower respiratory tract infections in preterm infants. However, recent data have suggested that RSV infection early in an infants life may cause subsequent chronic respiratory complications such as persistent wheezing.

Dr. Mark Polak, a neonatologist and professor of pediatrics from the West Virginia University School of Medicine and lead author of the economic analysis, noted, We factored in the potential costs of possible future complications and the quality of life associated with persistent wheezing and, based on these assumptions, our study found that preventing RSV early in life makes economic sense.

The authors noted that more evidence is needed to substantiate the linkage between Synagis and subsequent reductions in persistent wheezing.


'/>"/>

Contact: Tor Constantino
301-398-5801
Edelman Public Relations
Source:Eurekalert

Page: 1

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Fresh warnings to doctors regarding abortion pill
8. Researchers Present Data Regarding The Efficiency Of Herbs
9. Will anxiety regarding fertility treatment affect the chances of conception?
10. Changing Trends Regarding Insurance Cover For Weight Reduction Surgery
11. Indian Government warns Gujarat regarding possibility of bird flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , ... May 31, 2016 , ... TeaZa® Energy, ... herbal energy pouches, on World No Tobacco Day . The new flavor—Tropical ... locations later on this summer. , The new flavor is best described as ...
(Date:5/31/2016)... ... May 31, 2016 , ... Dr. Charles A. Ditta attained ... New Jersey in the class of 1986, where he graduated in the top ten ... current location in Livingston since 1989. He has been a member in good standing ...
(Date:5/31/2016)... ... May 31, 2016 , ... CURE ... patients with cancer, has added Cancer and Careers to its ... timely content on continuing successful careers while fighting cancer. , As partners, both ...
(Date:5/30/2016)... Viejo, California (PRWEB) , ... May 30, 2016 ... ... are easy to use inside of FCPX," said Christina Austin - CEO of ... created exclusively for use within Final Cut Pro X. Choose from abstract transitions ...
(Date:5/30/2016)... Lewisville, Texas (PRWEB) , ... May 30, 2016 , ... ... at 7 am in Plano, located at 3960 Legacy Drive, Plano, TX and is ... the Plano Chamber of Commerce followed by a medical open house. The Jasper High ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 , Isansys  Lifecare, a new ... Status Engine wireless patient monitoring platform, as it ships more ... Germany , Scotland and ... generation system, launched earlier this year, is now being used ... , This new technology significantly enhances the user ...
(Date:5/30/2016)... 30, 2016 Transparency Market Research ... Visualization Systems Market - Global Industry Analysis, Size, Share, ... the report, the global advanced (3D/4D) visualization systems market ... is anticipated to expand at a CAGR of 6.4% ... in 2024. Advanced (3D/4D) visualization systems have ...
(Date:5/30/2016)... , May 30, 2016 ... to reach USD 7.3 billion by 2024, according ... Inc. The increasing natality rate, the growing malnutrition ... as cancer and gastro-intestinal tract diseases are expected ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
Breaking Medicine Technology: